Search

Search Results

• PO:13:189 | Greater impact of psoriatic arthritis in females: is this mediated primarily by disease activity? Roberta Masnata¹, Valentina Boni¹, Giusy Peluso¹, Giulia Calabrese¹, Enrico De Lorenzis¹, Gerlando Natalello¹, Maria Antonietta D'Agostino¹, Augusta Ortolan¹. | ¹UOC Reumatologia e Immunologia Clinica- Fondazione Policlinico Agostino Gemelli IRCCS-Università Cattolica Sacro Cuore, Roma, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2030

  177

• PO:04:046 | Achieving Early Clinical Response was Associated with Cumulative Benefits on Disease Impact up to 2 Years in Patients with Active Psoriatic Arthritis Treated with Bimekizumab William Tillett^1|2, Joseph F Merola³, Iain B Mcinnes⁴, Kenneth B Gordon⁵, Richard B Warren⁶, Patrick Healy⁷, Jérémy Lambert⁸, Heather Edens⁹, Barbara Ink¹⁰, Paola Volpe¹¹, Laure Gossec¹² | ¹Royal National Hospital of Rheumatic Diseases Bath, United Kingdom; ²Department of Life Sciences, Centre for Therapeutic Innovation, University of Bath Bath, United Kingdom; ³Department of Dermatology and Department of Medicine, Division of Rheumatology, Utah Southwestern Medical Center Dallas, USA; ⁴College of Medical Veterinary and Life Sciences, University of Glasgow Glasgow, United Kingdom; ⁵Department of Dermatology, Medical College of Wisconsin Milwaukee, USA; ⁶Northern Care Alliance, NHS Foundation Trust and Manchester Academic Health Science Centre, University of Manchester Manchester, United Kingdom; ⁷UCB Morrisville, USA; ⁸UCB Colombes, France; ⁹UCB Smyrna, USA; ¹⁰UCB Slough, United Kingdom; ¹¹UOC Reumatologia, P.O. Spirito Santo Pescara, Italy; ¹²Sorbonne Universite and Pitie-Salpetriere Hospital Paris, France

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2295

  58

• CO:07:3 | Does articular and entheseal structural damage drive pain and patient-driven reported outcomes in difficult-to-treat psoriatic arthrtis patients? Results from a cross-sectional study Fabio Massimo Perrotta¹, Alen Zabotti², Mauro Fatica¹, Nicola Cabas², Andrea Guiotto², Nicoletta Franzolini³, Giovanni Striani², Maria De Martino⁴, Cristina De Nicola⁵, Miriam Isola⁴, Andrea Di Matteo⁶, Gabriele De Marco⁶, Denis McGonagle⁶, Ennio Lubrano¹, Luca Quartuccio⁴. | ¹Università degli studi del Molise, Campobasso; ²University Hospital Santa Maria della Misericordia, Udine; ³Presidio Ospedaliero S. Antonio, San Daniele del Friuli (UD); ⁴University of Udine; ⁵Epidemiology Unit, Italian Society for Rheumatology, Milano, Italy; ⁶University of Leeds, Leeds, UK

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1978

  189